IndiaTickerLatest filing: Marksans Pharma Ltd - 524404 - Shareholders Annual General Meeting To Be Held On August 27, 2026
ObservedCompany dossier
Marksans Pharma
NSE:MARKSANS · ISIN INE750C01026
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Marksans Pharma
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹681.8 Cr · PAT ₹105.1 Cr.
Exchange XBRLLatest ownership: promoter group 43.87% and public 56.13% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Marksans Pharma Ltd - 524404 - Shareholders Annual General Meeting To Be Held On August 27, 2026
BSE · exchange filing
Observed
Source filing Marksans Pharma Ltd - 524404 - Reg. 34 (1) Annual Report.
BSE · annual report
Observed
Source filing Marksans Pharma Ltd - 524404 - Business Responsibility and Sustainability Reporting (BRSR)
BSE · exchange filing
Observed
Source filing Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
BSE · conference call
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹681.8 Cr
- Profit after tax
- ₹105.1 Cr
- EPS
- ₹2.31
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 43.87%
- Public
- 56.13%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL